发明名称 |
Enantiomerically Pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-A]pyrimidin-9-yl)ethylamino]benzoic Acid, Its Use In Medical Therapy, And A Pharmaceutical Composition Comprising It - 026 |
摘要 |
The present invention relates to enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid or pharmaceutically acceptable salts thereof, it being in a solid state, its use in medical therapy, pharmaceutical composition comprising it, its use in the preparation of a medicament for use in a method for preventing or treating diseases, and its use in method for preventing or treating disease. The present invention relates to a selective inhibitor of phosphoinositide (PI) 3-kinase beta and use of the selective inhibitor in e.g. anti-thrombotic therapy.
|
申请公布号 |
US2009191177(A1) |
申请公布日期 |
2009.07.30 |
申请号 |
US20090359323 |
申请日期 |
2009.01.25 |
申请人 |
FJELLSTROM OLA;GUSTAFSSON DAVID;LINDBERG JAN A;JACKSON SHAUN |
发明人 |
FJELLSTROM OLA;GUSTAFSSON DAVID;LINDBERG JAN A.;JACKSON SHAUN |
分类号 |
C07D471/04;A61K31/5355;A61K31/727;A61K38/45;A61P7/00;A61P9/00 |
主分类号 |
C07D471/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|